Giving insulin before a meal ensures that its onset matches the absorption of glucose consumed during the meal.1,2 Clinicians use different types of insulin for mealtime doses. Compared with regular insulin, rapid-acting analog (RAA) insulins aspart, glulisine, and lispro act within minutes...
Short or rapid-acting insulin analogues allow a better postprandial glucose control and reduce hypoglycaemic risk. Clinical trials with insulin aspart and insulin lispro have demonstrated improved postprandial glucose control in comparison with human insulin, however, studies directly comparing the activities...
A rapid-acting analog insulin may be used to increase the insulin absorption rate in subcutaneous insulin. How long does intravenous insulin last in the body? Intravenous insulin acts rapidly and lasts for a very short duration in the body. To maintain the desired glucose levels in the blood,...
Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different.doi:10.2337/dc13-2535The article focuses on evidence-based factors supporting the use of rapid-acting insulin analogs in pregnant women with type 1 diabetes. It cites the results of studies which ...
Type of Insulin (Trade Names)SupplierAppearanceBegins WorkingPeak ActivityAll Gone Rapid Acting Afrezza(Regular insulin)MannKindInhaled12 Minutes30-45 Minutes2 Hours Fiasp®(insulin aspart)Novo NordiskClear16 - 20 minutes90 - 120 minutes5 - 6 hours ...
Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs This is a case report of a patient with allergy to the rapid acting insulins and rapid acting analogs. Before trying insulin desensitization the treatment ... MA Mollar-Puchades,IL Villanueva - ...
To compare quality of life (QoL) and treatment satisfaction in patients with Type 1 diabetes receiving the rapid-acting insulin analogue, insulin aspart (I... U Bott,S Ebrahim,S Hirschberger,... - 《Diabetic Medicine A Journal of the British Diabetic Association》 被引量: 78发表: 2010年 ...
Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences Clin Pharmacokinet (2020) J. Leohr et al. Ultra rapid lispro (URLi) accelerates insulin lispro absorption and insulin action vs Humalog® consistently across study populations: a ...
Human Insulin Analog (Insulin Aspart, IAsp) is Comparable to Human Insulin (HI) in Type 2 DiabetesWe studied the safety and efficacy of IAsp (a fast-acting insulin with a more rapid onset and shorter duration of action than-HI) in a 6-month, multic...
This trial compared the glycemic control, risk of hypoglycemia, and effect on body weight of insulin detemir and NPH insulin in patients with type 1 diabetes treated with rapid-acting insulin aspart at meals. RESEARCH DESIGN AND METHODS -- This study was a 6-month multinational open parallel-...